EP Plenary session - Joint debate on Patents

Patenti i prava uzgajivača bilja (rasprava)

Patents and plant breeders rights (debate)

Creation of unitary patent protection - Unitary patent protection - Jurisdictional system for patent disputes (debate)

Patenting of essential biological processes (debate)

Workshop - Policy Departements and Administration : Stem cell Research and patenting

ENVI

Enhanced cooperation in the area of the creation of unitary patent protection (debate)

JURI committee meeting. Exchange of views with Romanian Presidency. Presentation of study on Essential Patents and Internet of Things, commissioned by the European Parliament's Policy Department for Citizens' Rights and Constitutional Affairs at the request of JURI committee

Public Hearing - The Unitary patent : state of play in the context of Brexit

PAPADIMOULIS, Dimitrios (GUE/NGL, GR) - EP Vice-President

Plenary session week 51 2015 in Strasbourg - Patents and plant breeders rights - Oral question

Green meeting about patenting food and GMOs

JURI committee Hearing on Patent

Andreas MAVROYIANNIS, Raffaele BALDASSARRE, Martin SCHULZ - EP President

Lex Signing: European Unitary Patent Package

Plenary session week 50 -2012  in Strasbourg - European Patent

Press conference on the campaign against the patenting of biotechnical discoveries - No Patents on Life - with Nobel Prize for Literature winner Dario FO.

Martin SCHULZ - EP President, Evelyne GEBHARDT

Evelyne GEBHARDT and  M. THEN from No patents on Seeds Hand over a letter to Martin SCHULZ EP-President

Carl SCHLYTER, Raul ROMEVA I RUEDA, Elisabeth SCHROEDTER, Isabelle DURANT, Jose BOVE, Franziska BRANTNER, Martin HAUSLING, Jean-Paul BESSET, Nikos CHRYSOGELOS, Ulrike LUNACEK, Franziska KELLER

Greens / EFA group members stage a protest against patents in the agriculture sector

JURI Committee Meeting - Enhanced cooperation in the area of the creation of unitary patent protection with regard to the applicable translation arrangements

Illustration on the EU Patent at the Belgian Intellectual Property Office.

Press Conference on Biotechnical patents by: Eva LICHTENBERGER (Greens/EFA, AT) - Vittorio PRODI (S&D, IT) - Peter LIESE (EPP, DE)  - Miroslav MIKOLJIK (EPP, SL) - Carlo CASINI (EPP, IT)

Press conference in Strasbourg  : TRIPS and access to medicines - TRIPS : The EP was due to vote on whether to grant its assent to amending the TRIPS agreement to enable developing countries to make or import generic substitutes for patented medicines

Conference in Brussels on the European Patients' Rights day

No Software Patents demonstration at the EP in Strasbourg.

No Software Patents demonstration by the GreensEFA.

Intellectual property lies at the heart of innovation and competitiveness around the world as well as in the European Union. Intellectual property rights are protected mainly through patents, trademarks and copyright. They enable individuals and companies to earn recognition and/or financial benefit from what they invent or create. By striking the right balance between innovators and public interest, intellectual property aims to foster an environment in which creativity and innovation can flourish. But despite impressive patent activity, European businesses still encounter various challenges to register or protect patents. Restrictions: ©The material may not be edited and must be shown entirely.

EPRS - Key challenges for European patents

Parlament je raspravljao o tome treba li ukinuti patente za cjepiva protiv bolesti COVID-19 te je usvojio sveobuhvatniji program Erasmus+. Klima je također bila na dnevnom redu: Zastupnici su odobrili Fond za pravednu tranziciju kako bi pomogli regijama da se prilagode zelenoj tranziciji te su pozvali EU da učini više na zaštiti ekoloških aktivista. Zastupnici su također raspravljali o eskalaciji izraelsko-palestinskog sukoba.

Plenarne vijesti: Patenti za cjepiva protiv bolesti COVID-19, Erasmus+ i okoliš

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate proposal to the WTO to waive intellectual property rights for COVID-19 vaccines, a move backed by the US administration. Extracts from the debate: statements by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs, Valdis DOMBROVSKIS, Executive Vice-President of the EC in charge of an Economy that works for People, Esther de LANGE (EPP, NL), Iratxe GARCÍA PÉREZ (S&D, ES), Dacian CIOLOŞ (Renew, RO), Tilly METZ (Greens/EFA, LU), Marc BOTENGA (The Left, BE), and Gilles LEBRETON (ID, FR).

Waiver of the Global Covid 19 vaccines patents: extracts from the debate

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Closing statements by Valdis DOMBROVSKIS, Executive Vice-President of the European Commission in charge of an Economy that works for People, and Commissioner for Trade and by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Closing statements by Council and Comission

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 3/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 3/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 2/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 2/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Opening statements by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs and by Valdis DOMBROVSKIS, Executive Vice-President of the European Commission in charge of an Economy that works for People, and Commissioner for Trade.

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Opening statements Council and Commission

Parlament je ponovio svoj poziv na nesmetani pristup biljnom reprodukcijskom materijalu. Zastupnici žele osigurati da poljoprivrednici diljem EU-a mogu inovirati kako bi pronašli rješenja za klimatsku krizu i nove biljne bolesti. Bogatim multinacionalnim korporacijama ne treba dopustiti patentiranje prirodnog života, stvaranje monopola i podizanje cijena hrane.

Nema patenata na prirodno dobivene biljke i sjeme

Posljednja etapa jedinstvenog patenta EU-a rovovska je bitka, no novi i jednostavniji sustav smanjit će troškove i do 32.000 eura po patentu.

Rezanje troškova za patentiranje izuma

The single EU patent will have great advantages for EU businesses, believes Raffaele Baldassarre. Sophia in 't Veld names those violating fundamental rights in Europe.

7 Days: Battles for better rights and an EU patent

After 30 years of negotiation this might be the final act for a single EU patent. We talked to German MEP Bernhard Rapkay and Spanish MEP Antonio Masip Hidalgo.

Talking point: The EU patent, the final furlong?

MEPs try to make progress on the EU patent, question Member States' integrity and give their views on the Spanish bank bailout as farmers demand better milk prices.

EU patent / CIA flights / Spain / Milk

MEPs to take a calm look at the future of the European single patent after the storm over the Council's unilateral moves to change agreed text.

Patently problematic

It costs €2,000 in the US, and up to €40,000 in Europe. The single EU patent should make things simpler and cheaper, but its implementation is complicated.

Reporter: Patenting an invention across a continent

Protecting inventions across the EU could soon be possible on a smaller budget, but the devil is in the details. And more of today's headlines.

The News: EU Patent Pending

Protecting inventions across the EU could soon be possible on a smaller budget, but the devil is in the details.

25 EU countries opted to reform the European patent via enhanced cooperation. Is it the end of Europe as a community, or a great boost to our competitiveness?

5 rezultata